Associate Director, Medical Communications and Publications
$174k - $235k
- Location
- Cambridge, MA
- Workplace
- Hybrid
- Employment
- Full-time
About this role
Overview
The Associate Director, Medical Publications – TTR Franchise supports the strategic development and execution of the global medical publication plan for Alnylam’s transthyretin amyloidosis (TTR) franchise. Reporting to the Director, Medical publications – TTR Franchise, this role contributes to the planning, coordination, and delivery of high-impact publications supporting Alnylam’s medical strategy across cardiomyopathy and neuropathy programs.
As part of the Scientific Communications organization within Medical Affairs, the Associate Director partners closely with cross-functional stakeholders including Medical Directors, Clinical Development, Biostatistics, Scientific Communications, Legal, and Commercial teams to develop a global publication strategy, and ensure timely, accurate, and compliant dissemination of clinical and scientific data though peer-reviewed publications and presentations at major scientific congresses.
This is a highly collaborative and visible role requiring strong scientific expertise, operational excellence, and the ability to manage complex publication activities in a global matrixed environment.
This position may be hybrid (located in Cambridge, MA) or remote (located in the Eastern time zone).
Key Responsibilities
- Support the development and execution of the global TTR publication strategy aligned with medical affairs objectives and franchise priorities.
- Independently lead assigned components of the global publication plan across the lifecycle of evidence generation, including abstracts, posters, oral presentations, manuscripts, and plain language summaries.
- Proactively partner with Medical Directors, Clinical Development, and Biostatistics teams to identify publication opportunities aligned with strategic priorities.
- Coordinate cross-functional publication planning activities and contribute to Publication Working Group (PWG) operations.
- Collaborate with external authors, investigators, and key opinion leaders to support development and delivery of scientific publications.
- Provide direction to medical writing agencies and publication vendors to ensure high-quality and timely execution of deliverables.
- Ensure all publication activities comply with GPP, GPCAP, ICMJE criteria, and internal governance requirements.
- Support maintenance of publication timelines, trackers, and documentation within publications management systems.
- Represent Medical Publications in cross-functional discussions supporting evidence dissemination planning.
- Support Publication Steering Committees and Publication Planning Workshops where applicable.
- Lead and mentor junior publication team members as needed and foster a culture of scientific excellence and integrity.
- Demonstrate alignment with Alnylam core values in all internal and external interactions.
- Occasional travel (approx. 5 times annually) required to represent Alnylam at major congresses or attend company events
Qualifications
- PhD (preferred) or PharmD/MD with 5+ years of experience in the pharmaceutical/biotech industry, or medical communications agency.
- ISMPP Certified Medical Publication Professional (CMPP) certification – preferred.
- Prior medical affairs, medical communications, publications, agency and/or KOL management experience – required.
- Prior experience in rare disease, cardiology, neurology or RNA-based therapeutics – preferred.
- Experience supporting publication strategy and execution for a complex, global program – required.
- Strong working knowledge of GPP, GPCAP, ICMJE criteria, and industry best practices for publications – required.
- Demonstrated ability to work effectively in a cross-functional, matrixed environment – required.
- Excellent verbal and written communication skills; experience and high level of comfort interacting with scientific experts and senior stakeholders – required.
- Team management experience – preferred.
#LI-JB1 #LI-Hyrbid #LI-Remote
About Alnylam
We are the leader in RNAi therapeutics – a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of what’s possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce innovation, passion for excellence, purposeful urgency, open culture and commitment to people. We're proud to be a globally recognized top employer, where an authentic, inclusive culture and breakthrough thinking fuel one another.
At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. Qualified applicants will receive consideration for employment without regard to their sex, gender or gender identity, sexual orientation, race, color, ethnicity, national origin, ancestry, citizenship, religion, creed, physical or mental disability, pregnancy status or related conditions, genetic information, veteran or military status, marital or familial status, political affiliation, age, or any other factor protected by federal, state, or local law. Alnylam is an E-Verify Employer.
Before applying, please review Alnylam's Candidate Privacy Notice regarding how Alnylam handles Personal Data you provide with your application for employment.
The pay range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).
Alnylam’s robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.
Learn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website: https://www.alnylam.com/careers
Apply to Alnylam Pharmaceuticals
Clera fills in Alnylam Pharmaceuticals's application for you.
How it works
Open the role in Clera
Sign in, and this role opens on your Clera job board, ready to apply.
Clera fills in the application
Clera fills the form from your profile and resume, and asks what's missing.
Track it in Clera
Each application you send shows up in your Clera tracker, sorted by stage.
Ask your AI about this role
It knows you. Clera gives it the role.
First time? Connect Clera once, about a minute.
https://mcp.getclera.comSign in with your Clera account. MCP docs
About Alnylam Pharmaceuticals
SILENCE DISEASE. AMPLIFY LIFE.™
Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them.
Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, five more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases.
We are a global and diverse company of 2,600+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-25), Science Magazine (2018-25), Fast Company (Best Workplaces for Innovators 2020-25) and Great Place to Work.
We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America.
See our social media community guidelines: https://bit.ly/2FcRhJy.
Please note: If you wish to report an adverse event or product complaint, please email [email protected] or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861
Fraudulent Recruitment Activity
Be aware of the potential for scams and fraudulent recruitment activity from individuals claiming to represent Alnylam Pharmaceuticals. Alnylam never conducts its interview process via messaging apps, freelance sites, or social media platforms. Alnylam team members only communicate with potential candidates through an official Alnylam email address ending in "@alnylam.com."
- Team size
- 1,001-5,000 employees people
- Founded
- 2002
- Industry
- Biotechnology Research
- Workplace
- Hybrid
- Locations
- Cambridge, Massachusetts, United States
Benefits
- Medical coverage
- Dental coverage
- Vision coverage
- Life insurance
- Disability insurance
- Lifestyle reimbursement program
- Flexible spending account
- Health savings account
- 401(k) with company match
- Paid time off
- Wellness days
- Holidays
- Company-wide recharge breaks
- Family resources
- Family leave